R&D Changing Faces: Pharma and biotech hires, August 2026 August brought another wave of leadership changes across biotech, pharma, and research organisations.
News AI, genomics expert leaves Pathos AI, will advise Pfizer Pfizer is creating the role of AI Scholar for computational biologist Eric Schadt, who is leaving Pathos AI to start a new stealth venture.
R&D Changing Faces: Pharma and biotech hires, June & July 2026 In June/July, companies continued to reshape their leadership teams in preparation for upcoming clinical, regulatory, and commercial milestones.
R&D Changing Faces: Pharma and biotech hires, May 2026 Looking back to May, the pharma and biotech sector saw a steady stream of senior leadership changes.
R&D Changing Faces: Pharma and biotech, April 2026 April didn’t see too much activity at the big pharmas, but saw plenty of executive movement at small and midsized biotechs.
R&D Changing Faces: Pharma and biotech, March 2026 A broad mix of senior leadership and scientific and commercial appointments shaped last month’s pharma and biotech hiring activity.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
